About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes

NCT02548494·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Chattanooga-Hamilton County Hospital Authority

Age

1–21

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

T1DM
Hyperglycemia \>200 mg/dl
Bicarbonate ≤ 15 mmol/L
pH \< 7.3
Ketonemia
Ketonuria
Glucosuria
Admission to PICU (Pediatric Intensive Care Unit)
Ages 1-21 years

You may not be if

Patients who received glargine within the last 24 hours
Patients with sepsis

The record

StatusTerminated

PhaseNot applicable

Taking part17

StartedNov 2015

UpdatedSep 23, 2020

Conditions

Diabetes Mellitus, Type 1 Diabetic Ketoacidosis

Where1

Children's @ Erlanger
Chattanooga, Tennessee, United States